ArticleBlood cancer journal2021

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes.

Sijian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.